Breaking News Instant updates and real-time market news.

KL

Kirkland Lake Gold

$39.03 /

-0.58 (-1.46%)

05:39
05/22/20
05/22
05:39
05/22/20
05:39

Kirkland Lake downgraded to Sector Perform from Outperform at National Bank

National Bank analyst Mike Parkin downgraded Kirkland Lake Gold to Sector Perform from Outperform with a C$63 price target.

KL Kirkland Lake Gold
$39.03 /

-0.58 (-1.46%)

04/07/20 BofA
Kirkland Lake Gold initiated with a Buy at BofA
04/02/20 RBC Capital
RBC Capital maintains Outperform on Kirkland Lake Gold
03/24/20 Canaccord
Kirkland Lake Gold upgraded to Buy from Hold at Canaccord
03/18/20 CIBC
Kirkland Lake Gold upgraded to Outperformer from Neutral at CIBC

TODAY'S FREE FLY STORIES

Hot Stocks
Endeavour Mining publishes sustainability report » 07:18
05/27/20
05/27
07:18
05/27/20
07:18
EDVMF

Endeavour Mining

$0.00 /

+ (+0.00%)

Endeavour Mining…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDVMF Endeavour Mining
$0.00 /

+ (+0.00%)

EDVMF Endeavour Mining
$0.00 /

+ (+0.00%)

05/19/20 National Bank
Endeavour Mining price target raised to C$42 from C$36 at National Bank
05/04/20 Berenberg
Endeavour Mining price target raised to C$34 from C$31 at Berenberg
04/17/20 RBC Capital
Endeavour Mining price target raised to C$36 from C$34 at RBC Capital
04/02/20 RBC Capital
RBC Capital maintains Outperform on Endeavour Mining
Recommendations
Piedmont Lithium price target lowered to $20 from $28 at Roth Capital » 07:17
05/27/20
05/27
07:17
05/27/20
07:17
PLL

Piedmont Lithium

$7.76 /

-0.01 (-0.13%)

Roth Capital analyst Joe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLL Piedmont Lithium
$7.76 /

-0.01 (-0.13%)

Initiation
Nordex initiated with a Buy at Jefferies » 07:17
05/27/20
05/27
07:17
05/27/20
07:17
NRDXF

Nordex

$0.00 /

+ (+0.00%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
Moderna executives have sold more than $89M of stock this year, StatNews says » 07:16
05/27/20
05/27
07:16
05/27/20
07:16
MRNA

Moderna

$57.73 /

-11.27 (-16.33%)

Moderna's top five…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$57.73 /

-11.27 (-16.33%)

MRNA Moderna
$57.73 /

-11.27 (-16.33%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/20/20 Morgan Stanley
Moderna price target raised to $90 from $37 at Morgan Stanley
05/19/20 Piper Sandler
Piper trims Moderna target to $100 on capital raise dilution
05/19/20 BMO Capital
Moderna price target raised to $112 from $83 at BMO Capital
MRNA Moderna
$57.73 /

-11.27 (-16.33%)

MRNA Moderna
$57.73 /

-11.27 (-16.33%)

MRNA Moderna
$57.73 /

-11.27 (-16.33%)

MRNA Moderna
$57.73 /

-11.27 (-16.33%)

Upgrade
CNP Assurances upgraded to Buy from Hold at HSBC » 07:15
05/27/20
05/27
07:15
05/27/20
07:15
CNPAY

CNP Assurances

$0.00 /

+ (+0.00%)

HSBC analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNPAY CNP Assurances
$0.00 /

+ (+0.00%)

02/05/20 Exane BNP Paribas
CNP Assurances upgraded to Neutral from Underperform at Exane BNP Paribas
Hot Stocks
Medipharm, Argentia Gold to bring cannabis-infused products to Atlantic Canada » 07:14
05/27/20
05/27
07:14
05/27/20
07:14
MEDIF

Medipharm Labs

$0.00 /

+ (+0.00%)

MediPharm Labs and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

08/07/19 Roth Capital
Medipharm Labs initiated with a Buy at Roth Capital
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

Earnings
Euroseas reports Q1 adj. EPS 17c, two est. 36c » 07:12
05/27/20
05/27
07:12
05/27/20
07:12
ESEA

Euroseas

$2.33 /

+0.03 (+1.30%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESEA Euroseas
$2.33 /

+0.03 (+1.30%)

ESEA Euroseas
$2.33 /

+0.03 (+1.30%)

Recommendations
AutoZone price target raised to $1,105 from $967 at Goldman Sachs » 07:11
05/27/20
05/27
07:11
05/27/20
07:11
AZO

AutoZone

$1,123.19 /

+3.81 (+0.34%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

06:27 Today Nomura Instinet
AutoZone price target raised to $1,290 from $1,210 at Nomura Instinet
05/20/20 Nomura Instinet
AutoZone price target raised to $1,210 from $1,031 at Nomura Instinet
05/15/20 Cleveland Research
O'Reilly, AutoZone, Advance appear to be gaining share, says Cleveland Research
05/14/20 Wells Fargo
AutoZone price target raised to $1,175 from $1,050 at Wells Fargo
AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

Hot Stocks
BioLineRx's ongoing COMBAT trial featured in peer-reviewed journal » 07:11
05/27/20
05/27
07:11
05/27/20
07:11
BLRX

BioLineRx

$1.63 /

-0.76 (-31.80%)

BioLineRx announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLRX BioLineRx
$1.63 /

-0.76 (-31.80%)

BLRX BioLineRx
$1.63 /

-0.76 (-31.80%)

03/13/20 Oppenheimer
BioLineRx price target lowered to $11 from $26 at Oppenheimer
BLRX BioLineRx
$1.63 /

-0.76 (-31.80%)

Hot Stocks
Papa John's reports April, May period comparable sales » 07:09
05/27/20
05/27
07:09
05/27/20
07:09
PZZA

Papa John's

$74.13 /

-3.58 (-4.61%)

The company reports April…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

05/14/20 Northcoast
Papa John's sustaining strong comp growth as states reopen, says Northcoast
05/07/20 Stephens
Papa John's price target raised to $83 from $61 at Stephens
05/07/20 Credit Suisse
Papa John's price target raised to $84 from $71 at Credit Suisse
05/01/20 Northcoast
Papa John's downgraded to Neutral from Buy at Northcoast
PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

Hot Stocks
RedHill Biopharma planning development path toward RHB-106 approval in U.S. » 07:09
05/27/20
05/27
07:09
05/27/20
07:09
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

In January 2020, RedHill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Hot Stocks
RedHill Biopharma continues to advance development program for MAP bacteria » 07:09
05/27/20
05/27
07:09
05/27/20
07:09
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

RedHill announced in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Syndicate
Silicon Labs files to sell $500M of Convertible Senior Notes due 2025  07:09
05/27/20
05/27
07:09
05/27/20
07:09
SLAB

Silicon Labs

$95.84 /

+1.56 (+1.65%)

 
ShowHide Related Items >><<
SLAB Silicon Labs
$95.84 /

+1.56 (+1.65%)

SLAB Silicon Labs
$95.84 /

+1.56 (+1.65%)

04/30/20 Cowen
Silicon Labs price target raised to $115 from $100 at Cowen
04/06/20
Fly Intel: Top five analyst initiations
04/06/20 SMBC Nikko
Silicon Labs initiated with a Neutral at SMBC Nikko
03/13/20 Needham
Silicon Labs price target lowered to $100 from $115 at Needham
SLAB Silicon Labs
$95.84 /

+1.56 (+1.65%)

Hot Stocks
RedHill Biopharma plans to add third arm to Phase 2a study of opaganib » 07:08
05/27/20
05/27
07:08
05/27/20
07:08
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

RedHill has completed the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Recommendations
H.C. Wainwright ups Durect target to $6 on positive NASH data » 07:08
05/27/20
05/27
07:08
05/27/20
07:08
DRRX

Durect

$2.66 /

+0.19 (+7.69%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$2.66 /

+0.19 (+7.69%)

DRRX Durect
$2.66 /

+0.19 (+7.69%)

05/12/20 Cantor Fitzgerald
Durect risk/reward 'highly favorable' into Posimir decision, says Cantor
03/04/20 Cantor Fitzgerald
Cantor reiterates Overweight on Durect with $5 target post results
01/31/20 B. Riley FBR
B. Riley FBR starts Durect with Buy rating, $5 price target
01/31/20 B. Riley FBR
Durect initiated with a Buy at B. Riley FBR
DRRX Durect
$2.66 /

+0.19 (+7.69%)

DRRX Durect
$2.66 /

+0.19 (+7.69%)

DRRX Durect
$2.66 /

+0.19 (+7.69%)

DRRX Durect
$2.66 /

+0.19 (+7.69%)

Hot Stocks
RedHill Biopharma plans to initiate Phase 3 study of RHB-204 in Q3 » 07:07
05/27/20
05/27
07:07
05/27/20
07:07
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

Following recent data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Hot Stocks
Compugen doses first patient in COM701 Phase 1 monotherapy expansion cohort » 07:06
05/27/20
05/27
07:06
05/27/20
07:06
CGEN

Compugen

$14.28 /

-0.02 (-0.14%)

Compugen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGEN Compugen
$14.28 /

-0.02 (-0.14%)

CGEN Compugen
$14.28 /

-0.02 (-0.14%)

05/26/20 JMP Securities
Compugen resumed with an Outperform at JMP Securities
05/13/20
Fly Intel: Top five analyst initiations
05/13/20 Stifel
Compugen initiated with a Buy at Stifel
05/07/20
Fly Intel: Top five analyst initiations
CGEN Compugen
$14.28 /

-0.02 (-0.14%)

CGEN Compugen
$14.28 /

-0.02 (-0.14%)

Hot Stocks
Synthetic Biologics signs option to license SYN-020 for age-related diseases » 07:06
05/27/20
05/27
07:06
05/27/20
07:06
SYN

Synthetic Biologics

$0.34 /

+0.0113 (+3.49%)

Synthetic Biologics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYN Synthetic Biologics
$0.34 /

+0.0113 (+3.49%)

SYN Synthetic Biologics
$0.34 /

+0.0113 (+3.49%)

05/06/20 Alliance Global Partners
Synthetic Biologics price target lowered to $1.25 from $2.25 at Alliance Global
Hot Stocks
RedHill Biopharma aims to enroll up to 40 patients in Phase 2a study of opaganib » 07:06
05/27/20
05/27
07:06
05/27/20
07:06
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Initiation
Monarch Casino initiated with a Buy at SunTrust » 07:05
05/27/20
05/27
07:05
05/27/20
07:05
MCRI

Monarch Casino

$38.17 /

+1.1 (+2.97%)

SunTrust analyst Barry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCRI Monarch Casino
$38.17 /

+1.1 (+2.97%)

MCRI Monarch Casino
$38.17 /

+1.1 (+2.97%)

06:13 Today SunTrust
Monarch Casino initiated with a Buy at SunTrust
04/27/20 Stifel
Monarch Casino upgraded to Buy from Hold at Stifel
04/06/20 Jefferies
Eldorado has 'considerable upside' from Caesars merger, says Jefferies
01/06/20 Jefferies
Monarch Casino upgraded to Buy from Hold at Jefferies
MCRI Monarch Casino
$38.17 /

+1.1 (+2.97%)

Initiation
PDS Biotechnology initiated with a Buy at Alliance Global Partners » 07:05
05/27/20
05/27
07:05
05/27/20
07:05
PDSB

PDS Biotechnology

$1.17 /

-0.01 (-0.85%)

, MRK

Merck

$77.26 /

+0.89 (+1.17%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PDSB PDS Biotechnology
$1.17 /

-0.01 (-0.85%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

PDSB PDS Biotechnology
$1.17 /

-0.01 (-0.85%)

03/30/20 H.C. Wainwright
PDS Biotechnology downgraded to Neutral from Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
03/09/20 Noble Capital
PDS Biotechnology initiated with an Outperform at Noble Capital
11/07/19 H.C. Wainwright
PDS Biotechnology Q3 results miss, but studies on track, says H.C. Wainwright
MRK Merck
$77.26 /

+0.89 (+1.17%)

05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
04/27/20 SVB Leerink
Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/23/20 Mizuho
Merck business disruptions have been modest, says Mizuho
MRK Merck
$77.26 /

+0.89 (+1.17%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

Hot Stocks
First United Corp: Driver has issued another misleading message to shareholders » 07:05
05/27/20
05/27
07:05
05/27/20
07:05
FUNC

First United Corp

$14.54 /

+0.79 (+5.75%)

First United Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FUNC First United Corp
$14.54 /

+0.79 (+5.75%)

Recommendations
Kala Pharmaceuticals price target raised to $17 from $14 at H.C. Wainwright » 07:05
05/27/20
05/27
07:05
05/27/20
07:05
KALA

Kala Pharmaceuticals

$12.70 /

-0.37 (-2.83%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

05/13/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Kala after 'underwhelming' competitor data
03/20/20 Wedbush
Kala Pharmaceuticals added to Best Ideas List at Wedbush
03/18/20 H.C. Wainwright
Kala Pharmaceuticals price target raised to $13 from $10 at H.C. Wainwright
03/09/20 Jefferies
Kala's Eysuvis could be preferred treatment for dry eye flare, says Jefferies
KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

KALA Kala Pharmaceuticals
$12.70 /

-0.37 (-2.83%)

General news
FX Update: The dollar dropped back » 07:05
05/27/20
05/27
07:05
05/27/20
07:05

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
RedHill Biopharma expects initiation of Phase 3 study of RHB-204 in Q3 » 07:04
05/27/20
05/27
07:04
05/27/20
07:04
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.